AIRLINK 61.80 Decreased By ▼ -0.65 (-1.04%)
BOP 5.35 Increased By ▲ 0.01 (0.19%)
CNERGY 4.42 Decreased By ▼ -0.14 (-3.07%)
DFML 15.38 Decreased By ▼ -0.18 (-1.16%)
DGKC 65.05 Decreased By ▼ -1.23 (-1.86%)
FCCL 17.60 Increased By ▲ 0.10 (0.57%)
FFBL 27.48 Decreased By ▼ -0.37 (-1.33%)
FFL 9.37 Increased By ▲ 0.09 (0.97%)
GGL 9.99 Decreased By ▼ -0.09 (-0.89%)
HBL 104.30 Decreased By ▼ -1.35 (-1.28%)
HUBC 121.27 Decreased By ▼ -1.20 (-0.98%)
HUMNL 6.60 No Change ▼ 0.00 (0%)
KEL 4.41 Decreased By ▼ -0.07 (-1.56%)
KOSM 4.45 Increased By ▲ 0.02 (0.45%)
MLCF 35.53 Decreased By ▼ -0.58 (-1.61%)
OGDC 121.35 Decreased By ▼ -1.46 (-1.19%)
PAEL 22.45 Decreased By ▼ -0.57 (-2.48%)
PIAA 31.54 Increased By ▲ 2.20 (7.5%)
PIBTL 5.70 Decreased By ▼ -0.12 (-2.06%)
PPL 106.30 Decreased By ▼ -0.87 (-0.81%)
PRL 27.10 Decreased By ▼ -0.06 (-0.22%)
PTC 18.26 Decreased By ▼ -0.16 (-0.87%)
SEARL 52.20 Decreased By ▼ -0.78 (-1.47%)
SNGP 62.65 Decreased By ▼ -0.53 (-0.84%)
SSGC 10.45 Decreased By ▼ -0.34 (-3.15%)
TELE 9.05 Decreased By ▼ -0.24 (-2.58%)
TPLP 11.29 Decreased By ▼ -0.13 (-1.14%)
TRG 68.98 Decreased By ▼ -2.21 (-3.1%)
UNITY 23.50 Decreased By ▼ -0.24 (-1.01%)
WTL 1.27 Decreased By ▼ -0.01 (-0.78%)
BR100 6,927 Decreased By -16.4 (-0.24%)
BR30 22,575 Decreased By -252.1 (-1.1%)
KSE100 67,005 Decreased By -137 (-0.2%)
KSE30 22,050 Decreased By -40.2 (-0.18%)
World

EU regulator calls in experts over AstraZeneca jab

  • The Amsterdam-based regulator last week declared the jab was "safe and effective" and not linked to clotting.
Published March 25, 2021

THE HAGUE: The European Medical Agency (EMA) has announced it will convene a group of experts on Monday to delve further into incidents of blood clotting in people who have received AstraZeneca's Covid-19 vaccine.

The Amsterdam-based regulator last week declared the jab was "safe and effective" and not linked to clotting.

The group of medical experts and two representatives of the public will "provide additional input into the assessment", the EMA said in a statement on Thursday.

Numerous European countries quickly followed the EMA recommendation and lifted their suspensions of AstraZeneca vaccinations as infections and deaths continue to climb.

The agency declared, as did the World Health Organization, that the benefits from the jab continue to outweigh the risk of side effects.

But the EMA is pursuing investigations, noting a link could not definitively be ruled out to a rare clotting disorder.

The group convening on Monday will cover "aspects such as any plausible mechanism of action, possible underlying risk factors and any additional data needed to gain a deeper understanding of the observed events and the potential risk", an EMA statement said.

The outcome of the expert meeting will feed into the safety panel's updated health recommendation due to be published between April 6-9.

Comments

Comments are closed.